Antigua and Barbuda vs South-East Asia (WHO region): New cases tested for RR-/MDR-TB
Antigua and Barbuda
100.0%
in 2024
South-East Asia (WHO region)
91.0%
in 2024
Antigua and Barbuda rank
1st
South-East Asia (WHO region) rank
1st
New cases tested for RR-/MDR-TB over time
- Antigua and Barbuda
- South-East Asia (WHO region)
How they compare
Antigua and Barbuda currently reports 100.0% against 91.0% in South-East Asia (WHO region), a difference of 9.0%.
That makes Antigua and Barbuda's figure about 1.1 times South-East Asia (WHO region)'s.
The two have swapped places 1 time across 12 shared years of data; in 2009 it was South-East Asia (WHO region) ahead.
Antigua and Barbuda ranks 1st and South-East Asia (WHO region) ranks 1st of 192 countries.
South-East Asia (WHO region) has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Antigua and Barbuda | South-East Asia (WHO region) | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 0.1% | 0.1% | South-East Asia (WHO region) |
| 2010s | 0.0% | 17.8% | 17.8% | South-East Asia (WHO region) |
| 2020s | 33.3% | 80.0% | 46.7% | South-East Asia (WHO region) |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new cases tested for rr-/mdr-tb, Antigua and Barbuda or South-East Asia (WHO region)?
- Antigua and Barbuda, at 100.0% against 91.0% in South-East Asia (WHO region) as of 2024.
- What is the difference in new cases tested for rr-/mdr-tb between Antigua and Barbuda and South-East Asia (WHO region)?
- 9.0%, with Antigua and Barbuda ahead.
- How many years of comparable data are there for Antigua and Barbuda and South-East Asia (WHO region)?
- 12 years are reported by both, from 2009 to 2024.
- How do Antigua and Barbuda and South-East Asia (WHO region) rank globally for new cases tested for rr-/mdr-tb?
- Antigua and Barbuda ranks 1st and South-East Asia (WHO region) ranks 1st of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.